An experimental immunotherapy candidate targets toxic species of alpha-synuclein and was well tolerated in an ongoing, ...

Melbourne researchers have discovered more than 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader ...

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against ...

Melbourne researchers have discovered over 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader immunity ...

This year's prize celebrates computational tools that have transformed biology and have the potential to revolutionise drug ...

The synthetic peptide was inspired by ACE2, the protein to which the virus that causes COVID-19 binds to invade human cells.

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...

Projects focus on cancer therapies, robotic clot-removal catheters and mRNA vaccines, among other technologies ...

On Monday, SK revealed that it will spend $260 million to construct its fifth production site in its home country, this one ...

The University at Buffalo’s Center for Advanced Technology in Big Data and Health Sciences has awarded close to half a ...

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

Dr. Rajagopalan joins Brittany Davison, a Chartered Professional Accountant and owner of Davison CPA Consulting Inc., as an Advisor with BioVaxys from the former IMV, Inc. where she previously served ...